NCT05514314 2022-08-24
A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection
Peking University Cancer Hospital & Institute
Phase 2 Unknown
Clinical Trials
22 trialsNCT04797806 2021-03-15
SAINT
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT03992885 2019-06-20
Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT03983811 2019-06-12
Adjuvant Chemotherapy With or Without Intercalated Icotinib
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT03766490 2019-01-30
Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer
The First Affiliated Hospital of Soochow University
Phase NA Unknown
NCT03151161 2018-06-07
Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in â…¢b/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation
Sun Yat-sen University
Phase 2 Unknown
NCT01963195 2017-05-08
Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy
Anhui Medical University
Phase 2 Unknown
NCT03123484 2017-04-21
β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC
China Medical University, China
Phase 2 Unknown
NCT02883543 2016-08-30
First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 3 Unknown
NCT02778893 2016-05-20
Conmana Combined With Thalidomide to Treat NSCLC
Henan Provincial People's Hospital
Phase 4 Unknown
NCT02738983 2016-04-14
RT Plus EGFR-TKI for Wild-type NSCLC
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT02031601 2016-03-29
TCL-1
Qilu Hospital of Shandong University
Phase 4 Unknown
NCT02375581 2016-03-22
Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer
First People's Hospital of Hangzhou
Phase 2 Unknown
NCT02430974 2015-04-30
Chemotherapy of NSCLC With or Without Icotinib
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT02407366 2015-04-02
Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region
Phase 2 Unknown
NCT02375022 2015-03-24
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Phase 2 Unknown
NCT02009605 2015-03-05
Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer
Zhejiang University
Phase 2 Unknown
NCT02283424 2014-11-05
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Phase 4 Unknown
NCT02272127 2014-10-22
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT02191059 2014-07-31
Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01688713 2012-09-20
Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown